Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Mora

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Journal of Neurology|March 10, 2022
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progressionErica Tavazzi, Sebastian Daberdaku, Alessandro Zandonà, et al.
Neurobiology of Aging|May 20, 2009
Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutationAdriano Chiò, Gabriella Restagno, Maura Brunetti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 25, 2019
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based studyUmberto Manera, Andrea Calvo, Margherita Daviddi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 6, 2021
Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffsMaria Claudia Torrieri, Umberto Manera, Gabriele Mora, et al.
Cytotherapy|November 3, 2009
Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trialCorrado Tarella, Sergio Rutella, Francesca Gualandi, et al.
Neurobiology of Aging|September 22, 2018
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanismsAntonio Canosa, Giovanni De Marco, Annarosa Lomartire, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 2, 2021
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patientsLuca Diamanti, Paola Borrelli, Raffaele Dubbioso, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 15, 2016
A mapping review of international guidance on the management and care of amyotrophic lateral sclerosis (ALS)Astrid I W A Janssens, Marijke Ruytings, Ammar Al-Chalabi, et al.
Plos One|October 15, 2011
Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cellsGiovanni Nardo, Silvia Pozzi, Mauro Pignataro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 23, 2016
Influence of cigarette smoking on ALS outcome: a population-based studyAndrea Calvo, Antonio Canosa, Davide Bertuzzo, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Journal of Neurology|March 10, 2022
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progressionErica Tavazzi, Sebastian Daberdaku, Alessandro Zandonà, et al.
Neurobiology of Aging|May 20, 2009
Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutationAdriano Chiò, Gabriella Restagno, Maura Brunetti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 25, 2019
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based studyUmberto Manera, Andrea Calvo, Margherita Daviddi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 6, 2021
Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffsMaria Claudia Torrieri, Umberto Manera, Gabriele Mora, et al.
Cytotherapy|November 3, 2009
Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trialCorrado Tarella, Sergio Rutella, Francesca Gualandi, et al.
Neurobiology of Aging|September 22, 2018
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanismsAntonio Canosa, Giovanni De Marco, Annarosa Lomartire, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 2, 2021
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patientsLuca Diamanti, Paola Borrelli, Raffaele Dubbioso, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 15, 2016
A mapping review of international guidance on the management and care of amyotrophic lateral sclerosis (ALS)Astrid I W A Janssens, Marijke Ruytings, Ammar Al-Chalabi, et al.
Plos One|October 15, 2011
Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cellsGiovanni Nardo, Silvia Pozzi, Mauro Pignataro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 23, 2016
Influence of cigarette smoking on ALS outcome: a population-based studyAndrea Calvo, Antonio Canosa, Davide Bertuzzo, et al.
Pageof 12